PMS-CIPROFLOXACIN XL DIN 02416433
Status: Dormant
Holder: PHARMASCIENCE INC
Available to quote
Health Canada record
| Active ingredient(s) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN) 500 MG |
|---|---|
| Dosage form | Tablet (Immediate- And Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01MA02 CIPROFLOXACIN |
| Original market date | 14-Jan-2014 |
| Current status date | 31-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02247916 | CIPRO XL | BAYER INC | Tablet (Immediate- And Extended-Release) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN) 500 MG | Cancelled Post Market |
| 02416484 | MYLAN-CIPROFLOXACIN XL | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN) 1000 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14922 | 2013-11-21 | Abbreviated New Drug Submission (ANDS) |